A Novel Prognostic Signature in Osteosarcoma Characterised from the Perspective of Unfolded Protein Response.

Chengcheng Shi,Faming Zhao,Tingting Zhang,Denghui Xu,Zhuangyu Hao,Fengzhen Cui,Ji-Hua Shi,Yang Jin,Ningning Li,Caihong Yang,Yi Zhang,Xia Sheng

DOI: https://doi.org/10.1002/ctm2.750

IF: 8.554

2022-01-01

Clinical and Translational Medicine

Abstract:Dear Editor, Osteosarcoma (OS) is the most common primary malignant tumour of bone with variable molecular biology and prognosis. This makes better patient stratification and precision treatment an urgent clinical need.1 Activation of the unfolded protein response (UPR) is a hallmark of cancer cells facing endoplasmic reticulum (ER) stress,2,3 yet its clinical relevance inOS remains to be explored. By comprehensive interrogation of OS datasets established by us and others,4–7 the present study consolidates UPR activation as a critical molecular feature of OS and refines a prognostic gene signature from this perspective with translational potential. In this study (see Figure S1A for workflow), we assembled 5 independent OS cohorts (GSE99671, GSE126209, GSE21257, TARGET and Zhengzhou datasets), plus the TCGA sarcoma dataset. Three datasets (GSE99671, GSE126209 and Zhengzhou) with paired tumour and normal tissues were analysed for deregulated genes; two of them with relatively large sample size were further selected for pathway enrichment. Three datasets (GSE21257, TARGET and TCGA) with solely tumours and survival information for patient classification and prognostic model construction (Table S1). We first interrogated GSE99671 with paired tumour and normal samples, and identified 1581 differentially expressed genes (DEGs) [|log2 (fold change)| > .5 and adjust p value < .05] (Figure S1B). To our interest, several pathways related to ER function, such as response to ER stress and protein processing in ER, ranked top according to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses (Figure 1A and B). Enrichment of UPR and MYC targets was verified by Hallmark Gene Set Enrichement Analysis (GSEA) (Figures 1C and S1C), mirroring the recently established co-activation of UPR and MYC in multiple cancers.4,8 Meanwhile, transcriptomic analyses on 24 matched tumour and normal tissues collected in our hospital (hereafter referred to as Zhengzhou cohort) enriched similar